A study published in the Journal of Affective Disorders proposes a novel, fully automated artificial intelligence (AI) algorithm leveraging ExtraTrees (ET) forests to distinguish patients with major ...
Using a large multi-site dataset comprising 1,660 patients with major depressive disorder (MDD) and 1,340 healthy controls (HCs), researchers identified group-level differences in functional ...
Although antidepressants are a mainstay of MDD treatment, they are plagued by poor efficacy, high rates of relapse, and intolerable side effects. 40,41 Second-generation antidepressants, including ...
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental ...
A controlled clinical trial suggests a fast-acting psychedelic approach may reduce depressive symptoms, but researchers stress careful interpretation and the need for larger long-term studies. Study: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results